Drugs by condition
Drugs approved for bipolar disorder
Last checked: Nov 19, 2026Source: FDA labels (openFDA), Drugs@FDAMethods & limitations
Brand-name drugs approved
34
Still marketed, NDA or BLA
Drug classes
5
Novel drugs
13
New molecular entities and new biologics
In development
13
Investigational drugs in Phase 2 or 3
Newest approvals
The most recently first-approved brand-name drugs for bipolar disorder.
- Bysanti (Milsaperidone) · Vanda Pharms INC NovelFeb 20, 2026
- Subvenite (Lamotrigine) · Owp Pharms Sep 16, 2025
- Uzedy (Risperidone) · Teva Apr 28, 2023
- Abilify Asimtufii (Aripiprazole) · Otsuka Apr 27, 2023
- Rykindo (Risperidone) · Shandong Luye Jan 13, 2023
All approved drugs for bipolar disorder, by class
Every marketed NDA or BLA whose current FDA label names this condition in its Indications and Usage section, plus 194 generic labels. A drug can be approved for only part of a condition (one subtype or stage, or as add-on therapy), so check its label.
Atypical Antipsychotic (14)
- Lybalvi Olanzapine, Samidorphan L-Malate · Alkermes INC · 2021
- Caplyta Lumateperone Tosylate · Intra-Cellular · 2019
- Vraylar Cariprazine Hydrochloride · Abbvie · 2015
- Fanapt Iloperidone · Vanda Pharms INC · 2009
- Abilify Aripiprazole · Otsuka · 2002
- Geodon Ziprasidone Hydrochloride · Viatris · 2001
- Zyprexa Olanzapine · Cheplapharm · 1996
- Risperdal Risperidone · Janssen Pharms · 1993
- Uzedy Risperidone · Teva · 2023
- Abilify Asimtufii Aripiprazole · Otsuka · 2023
- Zyprexa Olanzapine · Cheplapharm · 2004
- Geodon Ziprasidone Mesylate · Viatris · 2002
- Zyprexa Zydis Olanzapine · Cheplapharm · 2000
- Risperdal Risperidone · Janssen Pharms · 1996
Anti-epileptic Agent (4)
- Lamictal Lamotrigine · Glaxosmithkline LLC · 1994
- Subvenite Lamotrigine · Owp Pharms · 2025
- Lamictal Odt Lamotrigine · Glaxosmithkline LLC · 2009
- Lamictal Cd Lamotrigine · Glaxosmithkline LLC · 1998
Central alpha-2 Adrenergic Agonist (1)
- Igalmi Dexmedetomidine Hydrochloride · Teva · 2022
Mood Stabilizer (1)
- Equetro Carbamazepine · Validus Pharms · 2004
Class not listed in FDA's data (14)
- Bysanti Milsaperidone · Vanda Pharms INC · 2026
- Latuda Lurasidone Hydrochloride · Sunovion Pharms INC · 2010
- Saphris Asenapine Maleate · Abbvie · 2009
- Seroquel Quetiapine Fumarate · Cheplapharm · 1997
- Rykindo Risperidone · Shandong Luye · 2023
- Abilify Maintena Kit Aripiprazole · Otsuka Pharm CO LTD · 2013
- Adasuve Loxapine · Nova Pneuma · 2012
- Seroquel Xr Quetiapine Fumarate · Cheplapharm · 2007
- Risperdal Consta Risperidone · Janssen Pharms · 2003
- Depakote Er Divalproex Sodium · Abbvie · 2000
- Depakote Divalproex Sodium · Abbvie · 1989
- Depakote Divalproex Sodium · Abbvie · 1983
- Lithium Carbonate Lithium Carbonate · Hikma · 1982
- Lithium Carbonate Lithium Carbonate · Hikma · 1980
Drugs in development for bipolar disorder
Investigational drugs FDA has not approved, in active or recent industry-sponsored Phase 2 and 3 trials for this condition. Phase 3 first.
- BrenipatideLY3537031Phase 313 trials
Eli Lilly · Alcohol Use Disorder, Irritable Bowel Syndrome, Depressive Disorder, Major
- AzetukalnerXEN1101Phase 39 trials
Xenon Pharmaceuticals Inc. · Focal Onset Seizures, Major Depressive Disorder, Bipolar Disorder
- BHV-7000Phase 36 trials
Biohaven Therapeutics Ltd. · Focal Epilepsy, Major Depressive Disorder, Bipolar Disorder
- NBI-1117568Phase 35 trials
Neurocrine Biosciences · Schizophrenia, Bipolar I Disorder, Mania
- RAP-219Phase 35 trials
Rapport Therapeutics Inc. · Focal Epilepsy, Epilepsy, Focal Seizure
- CYM-53093Navacaprant, NMRA-335140Phase 34 trials
Neumora Therapeutics, Inc. · Major Depressive Disorder, Major Depressive Episode Associated With Bipolar II Disorder
- LB-102Phase 34 trials
LB Pharmaceuticals Inc. · Schizophrenia, Bipolar I Disorder
- OLZSAM, ALKS 3831Phase 32 trials
Alkermes, Inc. · Bipolar I Disorder, Schizophrenia
- ABBV-932Phase 23 trials
AbbVie · Bipolar I or II Disorder, Generalized Anxiety Disorder (GAD), Bipolar I Disorder
- AL-001lithium salicylate, L-proline cocrystalPhase 23 trials
Beijing Anlong Biopharmaceutical Co., Ltd. · Wet Age-related Macular Degeneration (wAMD), Bipolar I Disorder
- ABX-002Phase 22 trials
Autobahn Therapeutics, Inc. · Major Depressive Disorder, Bipolar Disorder Depression
- IcalcaprantABBV-1354, CVL-354Phase 22 trials
AbbVie · Bipolar I Disorder, Bipolar II Disorder, Major Depressive Disorder
- ALTO-100Phase 21 trial
Alto Neuroscience · Bipolar Disorder I or II With a Major Depressive Episode
2 discontinued brand-name drugs whose label still names it
More on bipolar disorder: recruiting trials · published research
Related in psychiatry: Depression (major depressive disorder) · Schizophrenia · ADHD · Anxiety disorders · Insomnia · Opioid use disorder · Alcohol dependence · Smoking cessation · PTSD · Postpartum depression
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.